Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

A Review of the HIPAA, Part 2: Limitations, Rights, Violations, and role for the Imaging Technologist.

Moore W, Frye SA.

J Nucl Med Technol. 2019 Oct 11. pii: jnmt.119.227827. doi: 10.2967/jnmt.119.227827. [Epub ahead of print]

PMID:
31604900
2.

Development of Simple Methods to Reduce Radiation Exposure Rates to the Public from 18F-FDG PET/CT Patients.

Muzaffar R, Koester E, Frye S, Al-Enezi S, Sterkel B, Osman MM.

J Nucl Med Technol. 2019 Oct 11. pii: jnmt.119.233296. doi: 10.2967/jnmt.119.233296. [Epub ahead of print]

PMID:
31604894
3.

Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology.

Da C, Zhang D, Stashko M, Vasileiadi E, Parker RE, Minson KA, Huey MG, Huelse JM, Hunter D, Gilbert TSK, Norris-Drouin J, Miley M, Herring LE, Graves LM, DeRyckere D, Earp HS, Graham DK, Frye SV, Wang X, Kireev D.

J Am Chem Soc. 2019 Oct 2;141(39):15700-15709. doi: 10.1021/jacs.9b08660. Epub 2019 Sep 20.

PMID:
31497954
4.

TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.

Holtzhausen A, Harris W, Ubil E, Hunter DM, Zhao J, Zhang Y, Zhang D, Liu Q, Wang X, Graham DK, Frye SV, Earp HS.

Cancer Immunol Res. 2019 Oct;7(10):1672-1686. doi: 10.1158/2326-6066.CIR-19-0008. Epub 2019 Aug 26.

PMID:
31451482
5.

Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7.

Lamb KN, Bsteh D, Dishman SN, Moussa HF, Fan H, Stuckey JI, Norris JL, Cholensky SH, Li D, Wang J, Sagum C, Stanton BZ, Bedford MT, Pearce KH, Kenakin TP, Kireev DB, Wang GG, James LI, Bell O, Frye SV.

Cell Chem Biol. 2019 Oct 17;26(10):1365-1379.e22. doi: 10.1016/j.chembiol.2019.07.013. Epub 2019 Aug 15.

PMID:
31422906
6.

Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.

Wong JP, Stuhlmiller TJ, Giffin LC, Lin C, Bigi R, Zhao J, Zhang W, Bravo Cruz AG, Park SI, Earp HS, Dittmer DP, Frye SV, Wang X, Johnson GL, Damania B.

Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16541-16550. doi: 10.1073/pnas.1903991116. Epub 2019 Jul 25.

PMID:
31346082
7.

Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.

Blake DR, Vaseva AV, Hodge RG, Kline MP, Gilbert TSK, Tyagi V, Huang D, Whiten GC, Larson JE, Wang X, Pearce KH, Herring LE, Graves LM, Frye SV, Emanuele MJ, Cox AD, Der CJ.

Sci Signal. 2019 Jul 16;12(590). pii: eaav7259. doi: 10.1126/scisignal.aav7259.

8.

Functional passive range of motion of individuals with chronic cervical spinal cord injury.

Frye SK, Geigle PR, York HS, Sweatman WM.

J Spinal Cord Med. 2019 Jun 13:1-7. doi: 10.1080/10790268.2019.1622239. [Epub ahead of print]

PMID:
31192777
9.

Review of HIPAA, Part 1: History, Protected Health Information, and Privacy and Security Rules.

Moore W, Frye S.

J Nucl Med Technol. 2019 Dec;47(4):269-272. doi: 10.2967/jnmt.119.227819. Epub 2019 Jun 10. Review.

PMID:
31182664
10.

Strategies to Cope With Behavior Changes After Acquired Brain Injury.

Behe A, Dorsey N, Mahle C, Frye SK.

Arch Phys Med Rehabil. 2019 Jul;100(7):1381-1384. doi: 10.1016/j.apmr.2019.03.005. Epub 2019 May 3. No abstract available.

PMID:
31060788
11.

Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing.

Moussa HF, Bsteh D, Yelagandula R, Pribitzer C, Stecher K, Bartalska K, Michetti L, Wang J, Zepeda-Martinez JA, Elling U, Stuckey JI, James LI, Frye SV, Bell O.

Nat Commun. 2019 Apr 29;10(1):1931. doi: 10.1038/s41467-019-09628-6.

12.

Discovery of selective activators of PRC2 mutant EED-I363M.

Suh JL, Barnash KD, Abramyan TM, Li F, The J, Engelberg IA, Vedadi M, Brown PJ, Kireev DB, Arrowsmith CH, James LI, Frye SV.

Sci Rep. 2019 Apr 25;9(1):6524. doi: 10.1038/s41598-019-43005-z.

13.

The Need for Increased Awareness About Potential Quality Control Problems in Aging γ-Cameras.

Frye S, Frye R, Sterkel B, Muzaffar R, Osman MM.

J Nucl Med Technol. 2019 Sep;47(3):223-226. doi: 10.2967/jnmt.118.222489. Epub 2019 Apr 24.

PMID:
31019040
14.

A General TR-FRET Assay Platform for High-Throughput Screening and Characterizing Inhibitors of Methyl-Lysine Reader Proteins.

Rectenwald JM, Hardy PB, Norris-Drouin JL, Cholensky SH, James LI, Frye SV, Pearce KH.

SLAS Discov. 2019 Jul;24(6):693-700. doi: 10.1177/2472555219844569. Epub 2019 Apr 24.

15.

Diabetes management mediates the association between sleep duration and glycemic control in youth with type 1 diabetes mellitus.

Frye SS, Perfect MM, Silva GE.

Sleep Med. 2019 Aug;60:132-138. doi: 10.1016/j.sleep.2019.01.043. Epub 2019 Feb 16.

PMID:
30904394
16.

Addendum: A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1.

Stuckey JI, Dickson BM, Cheng N, Liu Y, Norris JL, Cholensky SH, Tempel W, Qin S, Huber KG, Sagum C, Black K, Li F, Huang XP, Roth BL, Baughman BM, Senisterra G, Pattenden SG, Vedadi M, Brown PJ, TBedford M, Min J, Arrowsmith CH, James LI, Frye SV.

Nat Chem Biol. 2019 Aug;15(8):846. doi: 10.1038/s41589-019-0242-5. No abstract available.

PMID:
30842648
17.

Am I (hyper)aroused or anxious? Clinical significance of pre-sleep somatic arousal in young adults.

Puzino K, Frye SS, LaGrotte CA, Vgontzas AN, Fernandez-Mendoza J.

J Sleep Res. 2019 Aug;28(4):e12829. doi: 10.1111/jsr.12829. Epub 2019 Feb 3.

PMID:
30714242
18.

Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.

Gu C, Stashko MA, Puhl-Rubio AC, Chakraborty M, Chakraborty A, Frye SV, Pearce KH, Wang X, Shears SB, Wang H.

J Med Chem. 2019 Feb 14;62(3):1443-1454. doi: 10.1021/acs.jmedchem.8b01593. Epub 2019 Jan 25.

19.

Correction: Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-β and Associated Transcripts in Pulmonary Fibrosis.

Vittal R, Mickler EA, Fisher AJ, Zhang C, Rothhaar K, Gu H, Brown KM, Emtiazjoo A, Lott JM, Frye SB, Smith GN, Sandusky GE, Cummings OW, Wilkes DS.

PLoS One. 2018 Dec 6;13(12):e0209107. doi: 10.1371/journal.pone.0209107. eCollection 2018.

20.

Correction to "Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID subunit 1".

Suh JL, Watts B, Stuckey JI, Norris-Drouin JL, Cholensky SH, Dickson BM, An Y, Mathea S, Salah E, Knapp S, Khan A, Adams AT, Strahl BD, Sagum CA, Bedford MT, James LI, Kireev DB, Frye SV.

Biochemistry. 2018 Dec 11;57(49):6806. doi: 10.1021/acs.biochem.8b01187. Epub 2018 Nov 28. No abstract available.

PMID:
30485080
21.

Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma.

Sinik L, Minson KA, Tentler JJ, Carrico J, Bagby SM, Robinson WA, Kami R, Burstyn-Cohen T, Eckhardt SG, Wang X, Frye SV, Earp HS, DeRyckere D, Graham DK.

Mol Cancer Ther. 2019 Feb;18(2):278-288. doi: 10.1158/1535-7163.MCT-18-0456. Epub 2018 Nov 27.

PMID:
30482852
22.

Usefulness of Topically Applied Sensors to Assess the Quality of 18F-FDG Injections and Validation Against Dynamic Positron Emission Tomography (PET) Images.

Lattanze RK, Osman MM, Ryan KA, Frye S, Townsend DW.

Front Med (Lausanne). 2018 Nov 1;5:303. doi: 10.3389/fmed.2018.00303. eCollection 2018.

23.

MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.

Lee-Sherick AB, Jacobsen KM, Henry CJ, Huey MG, Parker RE, Page LS, Hill AA, Wang X, Frye SV, Earp HS, Jordan CT, DeRyckere D, Graham DK.

JCI Insight. 2018 Nov 2;3(21). pii: 97941. doi: 10.1172/jci.insight.97941.

24.

Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group.

Zhao J, Zhang D, Zhang W, Stashko MA, DeRyckere D, Vasileiadi E, Parker RE, Hunter D, Liu Q, Zhang Y, Norris-Drouin J, Li B, Drewry DH, Kireev D, Graham DK, Earp HS, Frye SV, Wang X.

J Med Chem. 2018 Nov 21;61(22):10242-10254. doi: 10.1021/acs.jmedchem.8b01229. Epub 2018 Nov 5.

PMID:
30347155
25.

Childhood obesity, weight loss and developmental trajectories predict the persistence and remission of childhood sleep-disordered breathing.

Frye SS, Fernandez-Mendoza J, Calhoun SL, Gaines J, Vgontzas AN, Liao D, Bixler EO.

Pediatr Obes. 2019 Jan;14(1). doi: 10.1111/ijpo.12461. Epub 2018 Sep 6.

26.

A genomic view of experimental intraspecies and interspecies transformation of a rifampicin-resistance allele into Neisseria meningitidis.

Alfsnes K, Frye SA, Eriksson J, Eldholm V, Brynildsrud OB, Bohlin J, Harrison OB, Hood DW, Maiden MCJ, Tønjum T, Ambur OH.

Microb Genom. 2018 Nov;4(11). doi: 10.1099/mgen.0.000222. Epub 2018 Sep 25.

27.

Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.

Hopcraft SE, Pattenden SG, James LI, Frye S, Dittmer DP, Damania B.

PLoS Pathog. 2018 Sep 13;14(9):e1007267. doi: 10.1371/journal.ppat.1007267. eCollection 2018 Sep.

28.

MERTK Promotes Resistance to Irreversible EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancers Expressing Wild-type EGFR Family Members.

Yan D, Parker RE, Wang X, Frye SV, Earp HS 3rd, DeRyckere D, Graham DK.

Clin Cancer Res. 2018 Dec 15;24(24):6523-6535. doi: 10.1158/1078-0432.CCR-18-0040. Epub 2018 Sep 7.

PMID:
30194074
29.

MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents.

McDaniel NK, Cummings CT, Iida M, Hülse J, Pearson HE, Vasileiadi E, Parker RE, Orbuch RA, Ondracek OJ, Welke NB, Kang GH, Davies KD, Wang X, Frye SV, Earp HS, Harari PM, Kimple RJ, DeRyckere D, Graham DK, Wheeler DL.

Mol Cancer Ther. 2018 Nov;17(11):2297-2308. doi: 10.1158/1535-7163.MCT-17-1239. Epub 2018 Aug 9.

30.

Neurocognitive and behavioral significance of periodic limb movements during sleep in adolescents with attention-deficit/hyperactivity disorder.

Frye SS, Fernandez-Mendoza J, Calhoun SL, Vgontzas AN, Liao D, Bixler EO.

Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy129.

31.

Use of Protein Kinase-Focused Compound Libraries for the Discovery of New Inositol Phosphate Kinase Inhibitors.

Puhl-Rubio AC, Stashko MA, Wang H, Hardy PB, Tyagi V, Li B, Wang X, Kireev D, Jessen HJ, Frye SV, Shears SB, Pearce KH.

SLAS Discov. 2018 Oct;23(9):982-988. doi: 10.1177/2472555218775323. Epub 2018 May 29.

32.

Donated chemical probes for open science.

Müller S, Ackloo S, Arrowsmith CH, Bauser M, Baryza JL, Blagg J, Böttcher J, Bountra C, Brown PJ, Bunnage ME, Carter AJ, Damerell D, Dötsch V, Drewry DH, Edwards AM, Edwards J, Elkins JM, Fischer C, Frye SV, Gollner A, Grimshaw CE, IJzerman A, Hanke T, Hartung IV, Hitchcock S, Howe T, Hughes TV, Laufer S, Li VM, Liras S, Marsden BD, Matsui H, Mathias J, O'Hagan RC, Owen DR, Pande V, Rauh D, Rosenberg SH, Roth BL, Schneider NS, Scholten C, Singh Saikatendu K, Simeonov A, Takizawa M, Tse C, Thompson PR, Treiber DK, Viana AY, Wells CI, Willson TM, Zuercher WJ, Knapp S, Mueller-Fahrnow A.

Elife. 2018 Apr 20;7. pii: e34311. doi: 10.7554/eLife.34311.

33.

EO-1 data quality and sensor stability with changing orbital precession at the end of a 16 year mission.

Franks S, Neigh CSR, Campbell PK, Sun G, Yao T, Zhang Q, Huemmrich KF, Middleton EM, Ungar SG, Frye SW.

Remote Sens (Basel). 2017 May;9(5):412. doi: 10.3390/rs9050412. Epub 2017 Apr 27.

34.

Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1.

Suh JL, Watts B, Stuckey JI, Norris-Drouin JL, Cholensky SH, Dickson BM, An Y, Mathea S, Salah E, Knapp S, Khan A, Adams AT, Strahl BD, Sagum CA, Bedford MT, James LI, Kireev DB, Frye SV.

Biochemistry. 2018 Apr 10;57(14):2140-2149. doi: 10.1021/acs.biochem.8b00150. Epub 2018 Mar 28. Erratum in: Biochemistry. 2018 Dec 11;57(49):6806.

35.

Association Between Altered Hip Extension and Kinetic Gait Variables.

Wonsetler EC, Miller EL, Huey KL, Frye SE, Bowden MG.

Am J Phys Med Rehabil. 2018 Feb;97(2):131-133. doi: 10.1097/PHM.0000000000000840.

36.

Retraction of "The L3MBTL3 Methyl-Lysine Reader Domain Functions As a Dimer".

Baughman BM, Pattenden SG, Norris JL, James LI, Frye SV.

ACS Chem Biol. 2018 Jan 19;13(1):281. doi: 10.1021/acschembio.7b01061. Epub 2017 Dec 19. No abstract available.

37.

Novel Method to Detect and Characterize 18F-FDG Infiltration at the Injection Site: A Single-Institution Experience.

Muzaffar R, Frye SA, McMunn A, Ryan K, Lattanze R, Osman MM.

J Nucl Med Technol. 2017 Dec;45(4):267-271. doi: 10.2967/jnmt.117.198408. Epub 2017 Nov 10.

38.

The helicase DinG responds to stress due to DNA double strand breaks.

Frye SA, Beyene GT, Namouchi A, Gómez-Muñoz M, Homberset H, Kalayou S, Riaz T, Tønjum T, Balasingham SV.

PLoS One. 2017 Nov 9;12(11):e0187900. doi: 10.1371/journal.pone.0187900. eCollection 2017.

39.

The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis.

Branchford BR, Stalker TJ, Law L, Acevedo G, Sather S, Brzezinski C, Wilson KM, Minson K, Lee-Sherick AB, Davizon-Castillo P, Ng C, Zhang W, Neeves KB, Lentz SR, Wang X, Frye SV, Shelton Earp H 3rd, DeRyckere D, Brass LF, Graham DK, Di Paola JA.

J Thromb Haemost. 2018 Feb;16(2):352-363. doi: 10.1111/jth.13875. Epub 2018 Jan 12.

40.

First-in-Man Evaluation of 124I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment.

Laforest R, Dehdashti F, Liu Y, Frye J, Frye S, Luehmann H, Sultan D, Shan JS, Freimark BD, Siegel BA.

Mol Imaging. 2017 Jan-Dec;16:1536012117733349. doi: 10.1177/1536012117733349.

41.

Target class drug discovery.

Barnash KD, James LI, Frye SV.

Nat Chem Biol. 2017 Sep 19;13(10):1053-1056. doi: 10.1038/nchembio.2473. No abstract available.

42.

Neurocognitive and behavioral functioning in adolescents with sleep-disordered breathing: a population-based, dual-energy X-ray absorptiometry study.

Frye SS, Fernandez-Mendoza J, Calhoun SL, Gaines J, Sawyer MD, He F, Liao D, Vgontzas AN, Bixler EO.

Int J Obes (Lond). 2018 Jan;42(1):95-101. doi: 10.1038/ijo.2017.229. Epub 2017 Sep 19.

43.

High Prevalence of Dysgraphia in Elementary Through High School Students With ADHD and Autism.

Mayes SD, Breaux RP, Calhoun SL, Frye SS.

J Atten Disord. 2019 Jun;23(8):787-796. doi: 10.1177/1087054717720721. Epub 2017 Jul 25.

PMID:
28741400
44.

DprA from Neisseria meningitidis: properties and role in natural competence for transformation.

Hovland E, Beyene GT, Frye SA, Homberset H, Balasingham SV, Gómez-Muñoz M, Derrick JP, Tønjum T, Ambur OH.

Microbiology. 2017 Jul;163(7):1016-1029. doi: 10.1099/mic.0.000489. Epub 2017 Jul 21.

45.

Retraction: A High-Throughput Screening-Compatible Strategy for the Identification of Inositol Pyrophosphate Kinase Inhibitors.

Baughman BM, Wang H, An Y, Kireev D, Stashko MA, Jessen HJ, Pearce KH, Frye SV, Shears SB.

PLoS One. 2017 Jun 21;12(6):e0180272. doi: 10.1371/journal.pone.0180272. eCollection 2017. No abstract available.

46.

MerTK as a therapeutic target in glioblastoma.

Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, Ewend MG, Sulman EP, Gilbert MR, Earp HS, Miller CR.

Neuro Oncol. 2018 Jan 10;20(1):92-102. doi: 10.1093/neuonc/nox111.

47.

Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.

Barnash KD, The J, Norris-Drouin JL, Cholensky SH, Worley BM, Li F, Stuckey JI, Brown PJ, Vedadi M, Arrowsmith CH, Frye SV, James LI.

ACS Comb Sci. 2017 Mar 13;19(3):161-172. doi: 10.1021/acscombsci.6b00174. Epub 2017 Feb 22.

48.

Discovery of Macrocyclic Pyrimidines as MerTK-Specific Inhibitors.

McIver AL, Zhang W, Liu Q, Jiang X, Stashko MA, Nichols J, Miley MJ, Norris-Drouin J, Machius M, DeRyckere D, Wood E, Graham DK, Earp HS, Kireev D, Frye SV, Wang X.

ChemMedChem. 2017 Feb 3;12(3):207-213. doi: 10.1002/cmdc.201600589. Epub 2017 Jan 9.

49.

Aquatic Exercise for People With Spinal Cord Injury.

Frye SK, Ogonowska-Slodownik A, Geigle PR.

Arch Phys Med Rehabil. 2017 Jan;98(1):195-197. doi: 10.1016/j.apmr.2016.07.010. No abstract available.

PMID:
28010781
50.

Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors.

Wang X, Liu J, Zhang W, Stashko MA, Nichols J, Miley MJ, Norris-Drouin J, Chen Z, Machius M, DeRyckere D, Wood E, Graham DK, Earp HS, Kireev D, Frye SV.

ACS Med Chem Lett. 2016 Sep 13;7(12):1044-1049. eCollection 2016 Dec 8.

Supplemental Content

Support Center